Characteristics of women with type 2 diabetes mellitus and heart failure in Spain. The DIABET-IC study
Rodríguez-Padial, Luis (Hospital Universitario de Toledo)
Pérez Pérez, Antonio (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
Sánchez, Manuel Anguita (Hospital Universitario Reina Sofía (Còrdova, Espanya))
Barrios, Vivencio (Hospital Universitario Ramón y Cajal (Madrid))
Orna, José Antonio Gimeno (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza)
Muñiz, Javier (Universidade da Coruña)
Universitat Autònoma de Barcelona

Date:	2024
Abstract:	Heart failure (HF) is the second most common initial presentation of cardiovascular disease in people with type 2 diabetes mellitus (T2DM). T2DM carries an increased risk of HF in women. The aim of this study is to analyze the clinical characteristics and the treatment received by women with HF and T2DM in Spain. The DIABET-IC study included 1517 patients with T2DM in 2018-2019 in Spain, in 30 centers, which included the first 20 patients with T2DM seen in cardiology and endocrinology clinics. They underwent clinical evaluation, echocardiography, and analysis, with a 3-year follow-up. Baseline data are presented in this study. One thousand five hundred and seventeen patients were included (501 women; aged 67. 28 ± 10. 06 years). Women were older (68. 81 ± 9. 90 vs. 66. 53 ± 10. 06 years; p < 0. 001) and had a lower frequency of a history of coronary disease. There was a history of HF in 554 patients, which was more frequent in women (38. 04% vs. 32. 86%; p < 0. 001), and preserved ejection fraction being more frequent in them (16. 12% vs. 9. 00%; p < 0. 001). There were 240 patients with reduced ejection fraction. Women less frequently received treatment with angiotensin converting enzyme inhibitors (26. 20% vs. 36. 79%), neprilysin inhibitors (6. 00% vs. 13. 51%), mineralocorticoid receptor antagonists (17. 40% vs. 23. 08%), beta-blockers (52. 40% vs. 61. 44%), and ivabradine (3. 60% vs. 7. 10%) (p < 0. 001 for all), and 58% received guideline-directed medical therapy. A selected cohort with HF and T2DM attending cardiology and endocrinology clinics did not receive optimal treatment, and this finding was more pronounced in women.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Diabetes mellitus ; Heart failure ; Treatment ; Women
Published in:	Cardiology Journal, Vol. 31 (february 2024) , p. 103-110, ISSN 1898-018X

DOI: 10.5603/CJ.a2023.0016
PMID: 36896635

8 p, 205.1 KB

The record appears in these collections:
Articles > Research articles
Articles > Published articles